Journal Logo

You can read the full text of this article if you:

Ovid Member Institutional Access

Neoadjuvant Therapy for Resectable Pancreatic Cancer

A New Standard of Care. Pooled Data From 3 Randomized Controlled Trials

Birrer, Dominique L. MD; Golcher, Henriette MD; Casadei, Riccardo MD‡,§; Haile, Sarah R. PhD||; Fritsch, Ralph MD; Hussung, Saskia MD; Brunner, Thomas B. MD#; Fietkau, Rainer MD∗∗; Meyer, Thomas MD††; Grützmann, Robert MD, MBA; Merkel, Susanne MD; Ricci, Claudio MD‡,§; Ingaldi, Carlo MD‡,§; Di Marco, Mariacristina MD, PhD‡‡,§§; Guido, Alessandra MD; Serra, Carla MD; Minni, Francesco MD‡,§; Pestalozzi, Bernhard MD; Petrowsky, Henrik MD; DeOliveira, Michelle MD; Bechstein, Wolf O. MD||||; Bruns, Christiane J. MD¶¶; Oberkofler, Christian E. MD; Puhan, Milo MD, PhD||; Lesurtel, Mickaël MD, PhD##; Heinrich, Stefan MD∗∗∗; Clavien, Pierre-Alain MD, PhD

Author Information
doi: 10.1097/SLA.0000000000005126
  • Buy
  • SDC


Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.